Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Snyder-Robinson syndrome (SRS) is an X-linked intellectual disability syndrome, including also hypotonia, an unsteady gait, osteoporosis, kyphoscoliosis and facial asymmetry. Severe generalized psychomotor evolving to moderate to profound global intellectual disability is also observed.
Features include always present findings: Sparse eyebrow, Smooth philtrum, Hoarse voice, and Dental crowding and others; and common findings: Single transverse palmar crease, Kyphoscoliosis, Recurrent fractures, and Vertebral compression fracture and others. 51 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 6 | Seizure, Intellectual disability, Dysarthria |
Bones and joints | 6 | Kyphoscoliosis, Hyperextensibility of the finger joints, Weak and brittle bones (osteoporosis) |
Head and neck | 5 | Cleft palate, High, narrow palate, Facial asymmetry |
Muscles | 3 | Decreased muscle mass, Low muscle tone (hypotonia), Generalized hypotonia |
Growth and development | 2 | Short stature, Tall stature |
Arms and legs | 2 | Long fingers, Hyperextensibility of the finger joints |
Eyes | 1 | Ptosis |
Snyder-Robinson syndrome (SRS) is an X-linked intellectual disability (ID) syndrome belonging to the group of polyaminopathies (disorders related to the polyamine pathway). SRS has a specific clinical phenotype consisting of facial dysmorphism, asthenic build, progressive kyphoscoliosis, early-onset osteoporosis, ID, and seizures. To date, the authors are aware of around 100 individuals with a pathogenic variant in SMS [A Peron, unpublished data], and 31 affected males have been reported in the literature [, , , , , , , , , , , , , , , , ]. The following description of the phenotypic features associated with this condition is based on these reports. Table 2. Snyder-Robinson Syndrome: Frequency of Select Features
Feature | Proportion of Persons w/Feature | Comment |
|---|---|---|
Developmental delay | 31/31 | — |
Intellectual disability (ID) |
SMS function has not been fully characterized.
Syndromic X-linked intellectual disability Snyder type is caused by mutations in the SMS gene on chromosome X.
All individuals with SRS have deficient spermine synthase enzyme activity. However, as its prevalence in the general population has not been determined, penetrance of deficient spermine synthase activity as SRS cannot be estimated.
Source: GeneReviews — "Snyder-Robinson Syndrome"
Formal diagnostic criteria have not been established for Snyder-Robinson syndrome (SRS).
SRS should be suspected in males with the following clinical findings and family history.
Clinical findings
Developmental delay. Generalized psychomotor delay that begins in infancy typically affecting motor and speech development
Hypotonia due to poor muscular development
Ambulation abnormalities ranging from unsteady gait to inability to walk
Speech abnormalities. Nasal, dysarthric, coarse, or absent speech
Intellectual disability (ID). Typically in the moderate-to-severe range, but mild ID as well as profound ID have been described
• Asthenic body build and diminished body bulk
Source: GeneReviews — "Snyder-Robinson Syndrome"
X-linked intellectual disability (ID) syndromes with osteoporosis. Distinguishing between various forms of syndromic ID by clinical findings alone is often difficult because of overlapping clinical features, and diagnosis generally requires identification of the molecular cause. Nonetheless, Snyder-Robinson syndrome (SRS) can be distinguished from many forms of syndromic X-linked ID by the combination of hypotonia, facial dysmorphism, asthenic body build, and both early-onset osteoporosis and kyphoscoliosis. While kyphoscoliosis is visible, osteoporosis is not, although the presence of fractures is suggestive of it. Because osteoporosis is rare in X-linked ID, it can be utilized as a distinguishing feature and should certainly be considered in a male with fractures. X-linked ID syndromes with overlapping findings of SRS and osteoporosis are summarized in . Table 3. X-Linked Intellectual Disability Syndromes with Overlapping Findings of Snyder-Robinson Syndrome and Osteoporosis
Gene/ Genetic Mechanism | Disorder | Clinical Features of Disorder |
|---|---|---|
Overlapping w/SRS | Distinguishing from SRS Xp21 deletion involving:NR0B1GKDMDIL1RAPL11 |
Genetic testing for SMS is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for syndromic X-linked intellectual disability Snyder type has been reported in the published literature.
No approved treatments are currently available for syndromic X-linked intellectual disability Snyder type. The disease remains an area of unmet medical need.
Gene therapy approaches for syndromic X-linked intellectual disability Snyder type have been reported in the published literature.
Management guidelines are provided in several languages by the Snyder-Robinson Foundation. The following recommendations are based on management guidelines and the authors' personal experience managing individuals with this disorder.
To establish the extent of disease and needs in an individual diagnosed with SRS, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended.
Table 4.
Snyder-Robinson Syndrome: Recommended Evaluations Following Initial Diagnosis
System/Concern | Evaluation | Comment
| Developmental assessment | • To incl motor, adaptive, cognitive, speech-language eval
Eval for early intervention/ special education
| Neurologic eval | • Assessment for hypotonia
To incl brain MRI to assess abnormal calcification /or brain abnormalities
Consider EEG if seizures are a concern.
Constitutional
| Weight, length/height, head circumference | Assess for evidence of short stature, macrocephaly.
| Bone density assessment by DXA scan | To determine degree of osteoporosis need for calcium supplements or bisphosphonates1
Clinical eval for kyphoscoliosis, joint contractures, pectus deformities | Consider radiographic scoliosis survey based on clinical suspicion referral for orthopedic surgery as appropriate.
| Clinical eval incl feeding assessment |
| • Assessment for hypospadias cryptorchism
Renal ultrasound
Source: GeneReviews — "Snyder-Robinson Syndrome"
View trials for syndromic X-linked intellectual disability Snyder type
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended. Table 6. Snyder-Robinson Syndrome: Recommended Surveillance
System/Concern | Evaluation | Frequency |
|---|---|---|
Development | Monitor developmental progress educational needs. | At each visit |
Neurologic | Monitor those w/seizures as clinically indicated. | When medically indicated Osteoporosis |
Musculoskeletal | Physical medicine, OT/PT assessment of mobility, self-help skills | At each visit Genitourinary/ Kidney manifestations |
Family/Community | Assess family need for social work support (e.g., palliative/respite care, home nursing, other local resources), care coordination, or follow-up genetic counseling if new questions arise (e.g., family planning) | At each visit DXA = dual-energy x-ray absorptiometry; OT = occupational therapy; PT = physical therapy |
Source: GeneReviews — "Snyder-Robinson Syndrome"
Phenotype severity distribution: 22 always present features, 5 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for syndromic X-linked intellectual disability Snyder type.
14 publications have been identified in PubMed for syndromic X-linked intellectual disability Snyder type. Research spans Basic Science / Preclinical (50%), Gene Therapy / Novel Therapeutics (21%), and Review / Meta-Analysis (14%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 7 | 50% |
New treatment approaches | 3 | 21% |
Research summaries | 2 | 14% |
Testing and diagnosis research | 1 | 7% |
Patient case studies | 1 | 7% |
Tao X (2026). [PMID: 42250346](https://pubmed.ncbi.nlm.nih.gov/42250346/). *Mol Genet Metab*. [Gene Therapy / Novel Therapeutics]
VanSickle EA (2025). [PMID: 40382145](https://pubmed.ncbi.nlm.nih.gov/40382145/). *Methods in enzymology*. [Diagnostic / Biomarker]
Akinyele O (2025). [PMID: 40382143](https://pubmed.ncbi.nlm.nih.gov/40382143/). *Methods in enzymology*. [Gene Therapy / Novel Therapeutics]
Cressman A (2025). [PMID: 40382144](https://pubmed.ncbi.nlm.nih.gov/40382144/). *Methods in enzymology*. [Basic Science / Preclinical]
Civit A (2025). [PMID: 39523020](https://pubmed.ncbi.nlm.nih.gov/39523020/). *Clinical genetics*. [Case Report / Case Series]
Tao X (2025). [PMID: 40382141](https://pubmed.ncbi.nlm.nih.gov/40382141/). *Methods in enzymology*. [Basic Science / Preclinical]
Yerlikaya A (2025). [PMID: 41175261](https://pubmed.ncbi.nlm.nih.gov/41175261/). *Molecular biology reports*. [Basic Science / Preclinical]
VanSickle EA (2025). [PMID: 41410504](https://pubmed.ncbi.nlm.nih.gov/41410504/). *American journal of medical genetics. Part A*. [Gene Therapy / Novel Therapeutics]
Poudel P (2025). [PMID: 40302318](https://pubmed.ncbi.nlm.nih.gov/40302318/). *Frontiers in bioscience (Landmark edition)*. [Basic Science / Preclinical]
Yorgan TA (2024). [PMID: 39331754](https://pubmed.ncbi.nlm.nih.gov/39331754/). *Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research*. [Review / Meta-Analysis]
Data assembled from 8 of 12 sources · Last updated Sep 18, 2026, 2:11 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
31/31
Usually moderate to severe, but mild ID and profound ID have been reported |
Hypotonia | 26/30 | Usually present at birth is persistent |
Seizures | 18/30 | Musculoskeletal |
Asthenic body build | 30/31 | Low muscle mass |
Early-onset osteoporosis | 19/19 | Results in risk of fractures |
Kyphoscoliosis | 16/19 | Usually progressive |
Craniofacial features | 31/31 | Asymmetric face, midface hypoplasia, thick vermilion of the lower lip, high, narrow, or cleft palate Developmental delay. Hypotonia is usually present in the neonatal period and can persist into early childhood. |
Source: GeneReviews — "Snyder-Robinson Syndrome"
Xq21 deletion (complex glycerol kinase deficiency, infantile form; see NR0B1-Related Adrenal Hypoplasia Congenita) |
GRIA3 | GRIA3-related ID (OMIM 300699) | ID; Asthenic habitus; Seizures |
SLC16A2 | Allan-Herndon-Dudley syndrome (MCT8 deficiency) | ID; Hypotonia; muscle mass; Unsteady gait/ ataxia |
Different facial features Xp11.3 duplicationinvolving:MAOAMAOBNDP | Xp11.3 duplication2 | Moderate-to-severe ID; Osteoporosis; Scoliosis; Seizures; Speech abnormalities |
MED12 | Lujan-Fryns syndrome (See MED12-Related Disorders.) | ID; Thin habitus; Hypernasal voice |
Source: GeneReviews — "Snyder-Robinson Syndrome"